Tick-borne Encephalitis Vaccine
Class: Vaccines
Brands: TicoVac
Introduction
Tick-borne encephalitis vaccine is an inactivated vaccine prepared from tick-borne encephalitis (TBE) virus propagated in chick embryo fibroblast (CEF) cells.
Uses for Tick-borne Encephalitis Vaccine
Tick-borne encephalitis vaccine has the following uses:
Tick-borne encephalitis vaccine is indicated for active immunization to prevent tick-borne encephalitis (TBE). Tick-borne encephalitis vaccine is approved for use in individuals 1 year of age and older.
Tick-borne Encephalitis Vaccine Dosage and Administration
General
Tick-borne encephalitis vaccine is available in the following dosage form(s) and strength(s):
Tick-borne encephalitis vaccine is a suspension for injection supplied as a 0.25 mL or 0.5 mL single dose in pre-filled syringes.
Dosage
It isessentialthat the manufacturer's labeling be consulted for more detailed information on dosage and administration of this drug. Dosage summary:
Adults
For intramuscular use only.
1 through 15 years of age: 0.25 mL per dose
16 years of age and older: 0.5 mL per dose
1 through 15 years of age | 16 years of age and older | |
|---|---|---|
First dose | Day 0 | Day 0 |
Second dose | 1 to 3 months after the first vaccination | 14 days to 3 months after the first vaccination |
Third dose | 5 to 12 months after the second vaccination | 5 to 12 months after the second vaccination |
Complete the primary immunization series at least 1 week prior to potential exposure to TBEV (tick-borne encephalitis virus).
A booster dose (fourth dose) may be given at least 3 years after completion of the primary immunization series if ongoing exposure or re-exposure to TBEV is expected.
Bring the vaccine to room temperature before administration. Shake well prior to administration to thoroughly mix the vaccine suspension. After shaking, the vaccine should be a homogenous off-white, opalescent suspension. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not administer if particulate matter or discoloration remains after shaking. Administer vaccine by intramuscular injection.
